Portrait of Tiffany La
  • Telehealth visits
bch logo

Tiffany La, OD

She | Her | HersOptometry • Pediatric Optometry
Pediatric Ophthalmology & Optometry Oakland
877-822-4453
Portrait of Tiffany La
Portrait of Tiffany La
bch logo

Tiffany La, OD

She | Her | HersOptometry • Pediatric Optometry
Pediatric Ophthalmology & Optometry Oakland
877-822-4453

On this page

About me

Dr. Tiffany La is an optometrist who provides comprehensive eye exams for kids of all ages. She has a special interest in caring for infants and children, and particularly enjoys caring for those with special needs. Her training allows her to evaluate and manage binocular vision disorders, such as amblyopia (also known as lazy eye) and strabismus (misaligned eyes), in children. For patients with progressive myopia (nearsightedness), she offers management options, such as certain eye drops or contact lenses.

La earned her doctor of optometry degree from the Herbert Wertheim School of Optometry & Vision Science at the University of California, Berkeley. She completed a residency in pediatric optometry and binocular vision at the Illinois College of Optometry.

When not at work, La loves spending time with her husband and two young children. She enjoys going to her local library and exploring museums and parks with her family.

Education & training

Board certification

  • Optometry, National Board of Examiners in Optometry

Residency

  • Binocular Vision, University of Illinois College of Medicine-Chicago

Degree

  • OD, UC Berkeley School of Optometry

My expertise

Locations

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

    The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.